{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:27:20Z","timestamp":1762298840136,"version":"3.41.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005845","name":"Hyogo College of Medicine","doi-asserted-by":"publisher","award":["2015"],"award-info":[{"award-number":["2015"]}],"id":[{"id":"10.13039\/501100005845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K08603"],"award-info":[{"award-number":["15K08603"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.pbb.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T07:55:05Z","timestamp":1531468505000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex"],"prefix":"10.1016","volume":"172","author":[{"given":"Nobue","family":"Kitanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kandori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Muratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2018.07.002_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-2999(78)90176-0","article-title":"Muscimol antagonizes morphine hypermotility without potentiation of analgesia","volume":"48","author":"Christensen","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-6632.1986.tb23629.x","article-title":"Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats","volume":"473","author":"Di Chiara","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2018.07.002_bb0015","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2018.07.002_bb0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.07.002_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2018.07.002_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00115550-200705000-00012","article-title":"Understanding how opioids contribute to reward and analgesia","volume":"32","author":"Fields","year":"2007","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.pbb.2018.07.002_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(94)90342-5","article-title":"The role of dopamine D1-receptors in morphine-induced hyperlocomotion in mice","volume":"169","author":"Funada","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2018.07.002_bb0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0091-3057(82)90478-6","article-title":"Dopaminergic properties of nomifensine","volume":"17","author":"Gianutsos","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2018.07.002_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0773.1998.tb01390.x","article-title":"Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors","volume":"82","author":"Grung","year":"1998","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuroscience.2010.11.057","article-title":"A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception","volume":"175","author":"Hall","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2018.07.002_bb0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0022-3565(25)33515-9","article-title":"Selective antagonism of the antinociceptive effect of intrathecally applied alpha adrenergic agonists by intrathecal prazosin and intrathecal yohimbine","volume":"224","author":"Howe","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.07.002_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(00)01768-7","article-title":"Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice","volume":"299","author":"Ise","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2018.07.002_bb0065","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1080\/14656566.2016.1258063","article-title":"Dopamine depleters in the treatment of hyperkinetic movement disorders","volume":"17","author":"Jankovic","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.pbb.2018.07.002_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2018.07.002_bb0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000542-199708000-00035","article-title":"Antinociceptive interaction of intrathecal alpha2-adrenergic agonists, tizanidine and clonidine, with lidocaine in rats","volume":"87","author":"Kawamata","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2018.07.002_bb0080","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(98)00516-0","article-title":"No heroin or morphine 6\u03b2-glucuronide analgesia in \u03bc-opioid receptor knockout mice","volume":"355","author":"Kitanaka","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(03)02015-6","article-title":"Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration","volume":"474","author":"Kitanaka","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroscience.2004.09.026","article-title":"Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytryptamine turnover in the striatum","volume":"130","author":"Kitanaka","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2018.07.002_bb0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11064-006-9087-x","article-title":"Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor","volume":"31","author":"Kitanaka","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2018.07.002_bb0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neuroscience.2007.05.006","article-title":"Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors","volume":"147","author":"Kitanaka","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2018.07.002_bb0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11064-010-0132-4","article-title":"Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice","volume":"35","author":"Kitanaka","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2018.07.002_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2011.12.043","article-title":"Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice","volume":"1439","author":"Kitanaka","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2018.07.002_bb0115","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1523\/JNEUROSCI.12-07-02623.1992","article-title":"Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study","volume":"12","author":"Klitenick","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2018.07.002_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0091-3057(96)00123-2","article-title":"Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration","volume":"56","author":"Kuribara","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2018.07.002_bb0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ejp.708","article-title":"Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala","volume":"20","author":"Maire","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.pbb.2018.07.002_bb0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0143-4179(88)90072-8","article-title":"The ionic mechanisms underlying opioid actions","volume":"11","author":"McFadzean","year":"1988","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2018.07.002_bb0135","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neuropharm.2011.05.033","article-title":"Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration","volume":"61","author":"Meyer","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2018.07.002_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2014.08.040","article-title":"Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the alpha2A-adrenoceptor selective antagonist BRL44408","volume":"743","author":"Milne","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0145","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1523\/JNEUROSCI.23-03-01006.2003","article-title":"Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion","volume":"23","author":"Narita","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2018.07.002_bb0150","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1476-5381.1993.tb13919.x","article-title":"Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists","volume":"110","author":"Ocana","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199302000-00001","article-title":"Pharmacological mechanisms of opioid analgesics","volume":"16","author":"Pasternak","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/0897190018756512","article-title":"VMAT2 inhibitors for tardive dyskinesia\u2014practice implications","author":"Peckham","year":"2018","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.pbb.2018.07.002_bb0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1196\/annals.1369.016","article-title":"Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats","volume":"1074","author":"Pereira","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2018.07.002_bb0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","article-title":"Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants","volume":"102","author":"Pettibone","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuroscience.2013.07.008","article-title":"The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor","volume":"250","author":"Podurgiel","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2018.07.002_bb0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbr.2015.11.008","article-title":"The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine","volume":"298","author":"Podurgiel","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2018.07.002_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2018.02.006","article-title":"VMAT2 inhibitors for the treatment of tardive dyskinesia","volume":"389","author":"Scorr","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pbb.2018.07.002_bb0190","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pbb.2018.07.002_bb0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpain.2009.08.001","article-title":"Interaction of morphine with a new alpha2-adrenoceptor agonist in mice","volume":"11","author":"Sudo","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.pbb.2018.07.002_bb0205","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2018.07.002_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2017.10.003","article-title":"Potentiation of morphine-induced antinociception and locomotion by citalopram is accompanied by anxiolytic-like effects","volume":"163","author":"Varela","year":"2017","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718301886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718301886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T19:41:18Z","timestamp":1751744478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718301886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"alternative-id":["S0091305718301886"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2018.07.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}